Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Epstein-Barr Virus Infection of Mammary Epithelial Cells Promotes Malignant Transformation.

Hu H, Luo ML, Desmedt C, Nabavi S, Yadegarynia S, Hong A, Konstantinopoulos PA, Gabrielson E, Hines-Boykin R, Pihan G, Yuan X, Sotiriou C, Dittmer DP, Fingeroth JD, Wulf GM.

EBioMedicine. 2016 Jul;9:148-160. doi: 10.1016/j.ebiom.2016.05.025. Epub 2016 May 21.

2.

A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice.

Ogembo JG, Muraswki MR, McGinnes LW, Parcharidou A, Sutiwisesak R, Tison T, Avendano J, Agnani D, Finberg RW, Morrison TG, Fingeroth JD.

J Transl Med. 2015 Feb 6;13:50. doi: 10.1186/s12967-015-0415-2.

3.

Analysis of host gene expression changes reveals distinct roles for the cytoplasmic domain of the Epstein-Barr virus receptor/CD21 in B-cell maturation, activation, and initiation of virus infection.

Arredouani MS, Bhasin MK, Sage DR, Dunn LK, Gill MB, Agnani D, Libermann TA, Fingeroth JD.

J Virol. 2014 May;88(10):5559-77. doi: 10.1128/JVI.03099-13. Epub 2014 Mar 5.

4.

Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells.

Sun X, Bristol JA, Iwahori S, Hagemeier SR, Meng Q, Barlow EA, Fingeroth JD, Tarakanova VL, Kalejta RF, Kenney SC.

J Virol. 2013 Sep;87(18):10126-38. doi: 10.1128/JVI.01671-13. Epub 2013 Jul 10.

5.

Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor.

Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD.

Cell Rep. 2013 Feb 21;3(2):371-85. doi: 10.1016/j.celrep.2013.01.023. Epub 2013 Feb 14.

6.

SIRPĪ±/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen.

Ogembo JG, Milner DA Jr, Mansfield KG, Rodig SJ, Murphy GF, Kutok JL, Pinkus GS, Fingeroth JD.

J Immunol. 2012 May 1;188(9):4496-505. doi: 10.4049/jimmunol.1103086. Epub 2012 Apr 4.

7.

The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production.

Meng Q, Hagemeier SR, Fingeroth JD, Gershburg E, Pagano JS, Kenney SC.

J Virol. 2010 May;84(9):4534-42. doi: 10.1128/JVI.02487-09. Epub 2010 Feb 24.

8.

Epstein-Barr virus thymidine kinase is a centrosomal resident precisely localized to the periphery of centrioles.

Gill MB, Kutok JL, Fingeroth JD.

J Virol. 2007 Jun;81(12):6523-35. Epub 2007 Apr 11.

10.

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.

Hong YK, Foreman K, Shin JW, Hirakawa S, Curry CL, Sage DR, Libermann T, Dezube BJ, Fingeroth JD, Detmar M.

Nat Genet. 2004 Jul;36(7):683-5. Epub 2004 Jun 27.

PMID:
15220917
11.

EBV attachment stimulates FHOS/FHOD1 redistribution and co-aggregation with CD21: formin interactions with the cytoplasmic domain of human CD21.

Gill MB, Roecklein-Canfield J, Sage DR, Zambela-Soediono M, Longtine N, Uknis M, Fingeroth JD.

J Cell Sci. 2004 Jun 1;117(Pt 13):2709-20. Epub 2004 May 11.

12.
13.
14.

The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.

Prota AE, Sage DR, Stehle T, Fingeroth JD.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10641-6. Epub 2002 Jul 16.

15.

Herpesvirus infection of the liver.

Fingeroth JD.

Infect Dis Clin North Am. 2000 Sep;14(3):689-719. Review.

PMID:
10987116
16.

Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.

Oram RJ, Marcellino D, Strauss D, Gustafson E, Talarico CL, Root AK, Sharma PL, Thompson K, Fingeroth JD, Crumpacker C, Herold BC.

J Infect Dis. 2000 Apr;181(4):1458-61. Epub 2000 Apr 13.

PMID:
10762577
18.

Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells.

Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC.

Blood. 1999 Mar 1;93(5):1482-6.

19.

CD21-Dependent infection of an epithelial cell line, 293, by Epstein-Barr virus.

Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL.

J Virol. 1999 Mar;73(3):2115-25.

22.

Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.

Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD.

Blood. 1995 Mar 1;85(5):1289-99.

23.

Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course.

Shuhart MC, Myerson D, Childs BH, Fingeroth JD, Perry JJ, Snyder DS, Spurgeon CL, Bevan CA, McDonald GB.

Blood. 1994 Nov 1;84(9):3229-35.

24.

Zygomycosis due to Mucor circinelloides in a neutropenic patient receiving chemotherapy for acute myelogenous leukemia.

Fingeroth JD, Roth RS, Talcott JA, Rinaldi MG.

Clin Infect Dis. 1994 Jul;19(1):135-7.

PMID:
7948514
25.

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7.

Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM.

J Exp Med. 1991 Sep 1;174(3):625-31.

26.
27.

Proliferation of resting B cells is modulated by CR2 and CR1.

Fingeroth JD, Heath ME, Ambrosino DM.

Immunol Lett. 1989 Jun 15;21(4):291-301.

PMID:
2527816
28.

Identification of murine complement receptor type 2.

Fingeroth JD, Benedict MA, Levy DN, Strominger JL.

Proc Natl Acad Sci U S A. 1989 Jan;86(1):242-6.

29.

Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).

Fingeroth JD, Clabby ML, Strominger JD.

J Virol. 1988 Apr;62(4):1442-7.

30.

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT.

Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510-4.

Supplemental Content

Loading ...
Support Center